US Stock MarketDetailed Quotes

LFMD LifeMD

Watchlist
  • 5.040
  • +0.140+2.86%
Close Dec 20 16:00 ET
  • 5.180
  • +0.140+2.78%
Post 20:01 ET
218.29MMarket Cap-7.88P/E (TTM)

LifeMD Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

LifeMD Q3 2024 Earnings Date

Currency：USDNov 7, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
53.80M
53.39M
-403.41K
Miss Est.
+39.32%
+38.27%
-0.75%
EPS
-0.11
-0.14
-0.03
Miss Est.
+46.67%
+30.00%
-31.33%
Analyst Rating
Strong Buy

Dec 21, 2024

LifeMD Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 59.295M--
--2024/Q4-- / 57.433M--
Nov 7, 20242024/Q353.393M / 53.797M--
Aug 7, 20242024/Q250.662M / 48.165M--
May 8, 20242024/Q144.144M / 42.586M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 59.295M--
--2024/Q4-- / 57.433M--
Nov 7, 20242024/Q353.393M / 53.797M--
Aug 7, 20242024/Q250.662M / 48.165M--
May 8, 20242024/Q144.144M / 42.586M--

Unlock Free Earnings Estimates

LifeMD Earnings Reports

  • 10-Q: Q3 2024 Earnings Report

    Nov 8 11:35

  • 10-Q: Q2 2024 Earnings Report

    Aug 8 04:52

  • 10-Q: Q1 2024 Earnings Report

    May 9 04:51

  • LifeMD | 10-K: FY2023 Annual Report

    Mar 12 04:34

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 21, 2024

    Strong Buy

    • Buy

      83.33%

    • Hold

      16.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data